Vanda Pharmaceuticals, Inc. (VNDA) Misses Q1 Views
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $6.00 --0%
EPS Growth %: -30.4%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -30.4%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q1 EPS of ($0.28), $0.12 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.14 million versus the consensus estimate of $8.3 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
- Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
